Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients
- 1 July 1999
- journal article
- research article
- Published by Elsevier
- Vol. 18 (7) , 707-713
- https://doi.org/10.1016/s1053-2498(99)00023-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pathophysiology and treatment of lipid perturbation after cardiac transplantationCurrent Opinion in Cardiology, 1997
- Immunosuppression switch in pediatric heart transplant recipients: Cyclosporine to FK 506Journal of the American College of Cardiology, 1995
- Lipoprotein(a) and apolipoprotein changes after cardiac transplantationJournal of the American College of Cardiology, 1991
- Increased lipid peroxidation in cyclosporin-treated heart transplant recipientsThe American Journal of Cardiology, 1991
- Hypercholesterolemia after cardiac transplantation in childrenThe American Journal of Cardiology, 1990
- Effects of cyclosporine therapy on plasma lipoprotein levelsJAMA, 1989
- Frequency of hypercholesterolemia after cardiac transplantationThe American Journal of Cardiology, 1988
- Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipientsThe American Journal of Medicine, 1988